William Ashton Insider Trading $REPH Recro Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for William Ashton.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of William Ashton. William Ashton is Director in SPECTRUM PHARMACEUTICALS INC ($SPPI) and Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and Director in Galena Biopharma, Inc. ($GALE) and Director in Recro Pharma, Inc. ($REPH) and Director in Baudax Bio, Inc. ($BXRX).
William Ashton in Recro Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of William Ashton: Director
Holdings: 80,280 shares
Current Value: $646,254
Latest Transaction: Apr 22 2021
$REPH Market Capitalization: $98.40M
$REPH Previous Close: $8.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of William Ashton in Recro Pharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BXRX, REPH, SLS, SPPI, SCMP
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 2021 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | A | 1.71 | 38,012 | 65,001 | 38,012 | |
| Apr 22 2021 | REPH | Recro Pharma, Inc. | Ashton William | Director | Grant | A | 0.00 | 26,923 | 0 | 80,280 | 53.4 K to 80.3 K (+50.46 %) |
| May 11 2020 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | A | 8.37 | 12,405 | 103,830 | 12,405 | |
| May 11 2020 | REPH | Recro Pharma, Inc. | Ashton William | Director | Grant | A | 0.00 | 8,363 | 0 | 53,357 | 45 K to 53.4 K (+18.59 %) |
| Dec 09 2019 | REPH | Recro Pharma, Inc. | Ashton William | Director | Grant | A | 0.00 | 17,582 | 0 | 44,994 | 27.4 K to 45 K (+64.14 %) |
| May 10 2019 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | A | 8.80 | 10,888 | 95,814 | 10,888 | |
| May 10 2019 | REPH | Recro Pharma, Inc. | Ashton William | Director | Grant | A | 0.00 | 7,955 | 0 | 27,412 | 19.5 K to 27.4 K (+40.89 %) |
| May 14 2018 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | M | 0.00 | 13,274 | 0 | 0 | |
| May 14 2018 | REPH | Recro Pharma, Inc. | Ashton William | Director | Buy | M | 0.00 | 13,274 | 0 | 19,457 | 6.2 K to 19.5 K (+214.69 %) |
| May 08 2018 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | A | 11.32 | 5,742 | 64,999 | 5,742 | |
| May 08 2018 | REPH | Recro Pharma, Inc. | Ashton William | Director | Grant | A | 0.00 | 6,183 | 0 | 6,183 | 0 to 6.2 K |
| May 16 2017 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | A | 0.00 | 13,274 | 0 | 13,274 | |
| Dec 18 2015 | REPH | Recro Pharma, Inc. | Ashton William | Director | Option Exercise | A | 8.41 | 10,000 | 84,100 | 10,000 |
Page: 1